Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancements and challenges in CAR T cell therapy in autoimmune diseases
Georg Schett, Fabian Müller, Jule Taubmann, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 9, pp. 531-544
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
Yaxian Kong, Jingyao Li, Xia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Advances in Targeted Therapy for Systemic Lupus Erythematosus: Current Treatments and Novel Approaches
Kaoru Saegusa, Yumi Tsuchida, Toshihiko Komai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 929-929
Open Access | Times Cited: 1
B-Cell-Depleting Immune Therapies as Potential New Treatment Options for Systemic Sclerosis
Gerhard Zugmaier, Matthias Klinger, Marion Subklewe, et al.
Sclerosis (2025) Vol. 3, Iss. 1, pp. 5-5
Open Access | Times Cited: 1
Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study
Kathleen M.M. Vanni, Kaitlin R McCarter, Xiaosong Wang, et al.
The Lancet Rheumatology (2025)
Closed Access | Times Cited: 1
Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials
Liuting Zeng, Chang Liu, Yang Wu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Characterization of a 3S PRAME VLD-Specific T Cell Receptor and Its Use in Investigational Medicinal Products for TCR-T Therapy of Patients with Myeloid Malignancies
Maja Bürdek, Petra U. Prinz, Kathrin Mutze, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 242-242
Open Access
Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases
Alejandrina Hernández-López, Alberto Olaya‐Vargas, Juan Carlos Bustamante Ogando, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 156-156
Open Access
Maladies auto-immunes et sclérose en plaques : le défi thérapeutique
G. Androdias
Pratique Neurologique - FMC (2025)
Open Access
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
Qiaolin Huang, Xiaojian Zhu, Yicheng Zhang
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Synthetic Receptor-Based Cell Therapies for Autoimmune Diseases: An Update
Mieszko Lachota, Radosław Zagożdżon
Cytotherapy (2025)
Open Access
A comprehensive review on the potential health effects of anthocyanins in modulating autoimmune disease
Guangyi Du, Lianghua Xie, Ming Zhang, et al.
Food Bioscience (2025) Vol. 66, pp. 106245-106245
Closed Access
Therapeutic advances in multiple sclerosis: Novel therapies (immune checkpoint inhibitors, CAR-T, Anti-CD40L)
Sarah Conway, Kristin Galetta
Neurotherapeutics (2025), pp. e00558-e00558
Open Access
Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics
M.A. Karsdal, Thomas R. Cox, Amelia L. Parker, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1856-1856
Open Access
Precise CAR-T-cell Therapy Targeting Non-Cancerous Diseases: Advances in Precision Medicine and Bioengineering
Chaojie Zhu, Fangzhou Wang, Zesheng Cheng, et al.
Precision medicine and engineering. (2025), pp. 100024-100024
Open Access
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
Xiaofeng Dai, Yuting Fan, Xiaofeng Zhao
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
γδ T cells and head and neck squamous cell carcinoma
Jiayu Peng, Huibin Qiu, Lin‐Lin Bu, et al.
International review of cell and molecular biology (2025)
Closed Access
Plasmid-based electroporation for efficient genetic engineering in immortalized T lymphocytes
Yuqing Xie, Martin Fussenegger
Metabolic Engineering (2025)
Open Access
Progress and challenges in developing allogeneic cell therapies
T. Deuse, Sonja Schrepfer
Cell stem cell (2025) Vol. 32, Iss. 4, pp. 513-528
Open Access
Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
Lvying Wu, Lingfeng Zhu, Jin Chen
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Integration of transcriptome and immunophenotyping data highlights differences in the pathogenetic kinetics of B cells across immune-mediated disease
Shinji Izuka, Toshihiko Komai, Takahiro Itamiya, et al.
RMD Open (2025) Vol. 11, Iss. 2, pp. e005310-e005310
Open Access
Epigenetically Reprogrammed Nanovesicles as Inverse Vaccines for Antigen-Specific Immune Tolerance in Autoimmune Diseases
Yue Xi, Hui Feng, Xue Liu, et al.
Nano Letters (2025)
Closed Access
Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders
Azhagu Madhavan Sivalingam
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Rheumatoid arthritis unmasked: the power of B cell depletion therapy
Tawfeeq Alghazali, Raed Obaid Saleh, Subasini Uthirapathy, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
CAR-T-Zelltherapie bei neuroimmunologischen Erkrankungen
Jeremias Motte, Ralf Gold
InFo Neurologie + Psychiatrie (2025) Vol. 27, Iss. 2, pp. 34-43
Closed Access
Chimeric Antigen Receptor T-cell therapy in pediatric refractory systemic lupus erythematosus
Xue He, Fei Liu, Meiping Lu, et al.
The Innovation Medicine (2025), pp. 100119-100119
Closed Access
Page 1 - Next Page

Scroll to top